Uloric (febuxostat) Demonstrated Efficacy for Management of …
October 18th, 2009
| Tags: development, dieting, management, medical, north-america, pill-identifier, study, support-groups, takeda, uloric
The CONFIRMS trial randomized 2269 patients with gout and sUA greater than or equal to 8.0 mg/dL to receive six months of daily treatment with ULORIC 40 mg, 80 mg or allopurinol 300 mg (or 200 mg if baseline estimated creatinine … Liver Enzyme Elevations: In randomized controlled studies, transaminase elevations greater than 3 times the upper limit of normal (ULN) were observed (AST: 2%, 2%, and ALT: 3%, 2% in ULORIC and allopurinol-treated patients, respectively). …
Here is the original:
Uloric (febuxostat) Demonstrated Efficacy for Management of …
Leave a comment
| Trackback
